Alexandre Wicky
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 8
- Cutaneous Melanoma Detection and Management 2
- CAR-T cell therapy research 2
- Colorectal Cancer Treatments and Studies 1
-
- Melanoma and MAPK Pathways 4
- Co-authors
- Olivier Michielin (13 shared papers)Camille L. Gérard (10 shared papers)Michel A. Cuendet (10 shared papers)Krisztián Homicskó (5 shared papers)Julie Delyon (3 shared papers)Aristomenis K. Exadaktylos (1 shared paper)Pierre‐Nicolas Carron (1 shared paper)Julien Vionnet (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Frontiers in Oncology (2 papers)Annals of Oncology (2 papers)Cancers (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Alexandre Wicky
16 papers receiving 163 citations
Peers
Comparison fields: 5 of 53
- Oncology 94
- Health Informatics 3
- Immunology 42
- Pulmonary and Respiratory Medicine 43
- Hepatology 9
Countries citing papers authored by Alexandre Wicky
This map shows the geographic impact of Alexandre Wicky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Wicky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Wicky more than expected).
Fields of papers citing papers by Alexandre Wicky
This network shows the impact of papers produced by Alexandre Wicky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Wicky. The network helps show where Alexandre Wicky may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexandre Wicky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 72 | |
| 2 | 2019 | 23 | |
| 3 | 2022 | 20 | |
| 4 | 2019 | 15 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2020 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2021 | 1 |
About Alexandre Wicky
Alexandre Wicky is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 16 papers that have together received 164 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Melanoma and MAPK Pathways (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Cutaneous Melanoma Detection and Management (2 papers), CAR-T cell therapy research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Oncology (94 citations), Health Informatics (3 citations), Immunology (42 citations), Pulmonary and Respiratory Medicine (43 citations) and Hepatology (9 citations). Alexandre Wicky has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Olivier Michielin, Camille L. Gérard, Michel A. Cuendet, Krisztián Homicskó, Julie Delyon, Aristomenis K. Exadaktylos, Pierre‐Nicolas Carron, Julien Vionnet, Luis Schiappacasse and Hasna Bouchaab. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Annals of Oncology, Cancers and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.